Cargando…

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension

Detalles Bibliográficos
Autores principales:	Tandon, Puneeta, Abraldes, Juan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632248/ https://www.ncbi.nlm.nih.gov/pubmed/26458850 http://dx.doi.org/10.4103/1319-3767.166204

Ejemplares similares

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

Carvedilol Ameliorates Intrahepatic Angiogenesis, Sinusoidal Remodeling and Portal Pressure in Cirrhotic Rats
por: Ling, Liping, et al.
Publicado: (2018)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis
por: Li, Tong, et al.
Publicado: (2016)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension
por: Wei, Zhen-gang, et al.
Publicado: (2018)

The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis
por: Chen, Sheng, et al.
Publicado: (2015)

CARVEDILOL AS PRIMARY PROPHYLAXIS FOR GASTRIC VARICEAL BLEEDING IN PORTAL HYPERTENSION MODEL IN RATS
por: BERTOLDI, Andressa de Souza, et al.
Publicado: (2020)

Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension
por: Wani, Zeeshan Ahmad, et al.
Publicado: (2017)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
por: Frishman, William H, et al.
Publicado: (2008)

Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension
por: Cheong, Hoi I, et al.
Publicado: (2018)

Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Thenappan, Thenappan, et al.
Publicado: (2021)

Preclinical Evidences for an Antimanic Effect of Carvedilol
por: de Souza, Greicy Coelho, et al.
Publicado: (2015)

Carvedilol for the treatment of red scrotum syndrome
por: Merhi, Ribal, et al.
Publicado: (2017)

Hot Melt Coating of Amorphous Carvedilol
por: Bannow, Jacob, et al.
Publicado: (2020)

Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis
por: Paik, Yong-Han
Publicado: (2016)

A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose
por: Eiamart, Wanna, et al.
Publicado: (2022)

Effect of hydroxylpropyl-β-cyclodextrin on Solubility of Carvedilol
por: Shewale, B. D., et al.
Publicado: (2008)

Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
por: Barold, S. Serge, et al.
Publicado: (2018)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

How Carvedilol activates β(2)-adrenoceptors
por: Benkel, Tobias, et al.
Publicado: (2022)

Hypertensive heart disease: Benefit of carvedilol in hemodynamic, left ventricular remodeling, and survival
por: Dominguez, Renata F, et al.
Publicado: (2019)

Cyclodextrine Screening for the Chiral Separation of Carvedilol by Capillary Electrophoresis
por: Hancu, Gabriel, et al.
Publicado: (2015)

Carvedilol in the treatment of elderly patients with chronic heart failure
por: Witte, Klaus KA, et al.
Publicado: (2008)

Carvedilol dihydrogen phosphate hemihydrate: a powder study
por: Chernyshev, Vladimir V., et al.
Publicado: (2009)

The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
por: Eichhorn, Eric J, et al.
Publicado: (2001)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease
por: Miranda, Carla Paixão, et al.
Publicado: (2014)

Clinical effects of carvedilol and trimetazidine for the treatmentof alcoholic myocardiopathy
por: Li, Hui, et al.
Publicado: (2016)

Severe carvedilol toxicity without overdose – caution in cirrhosis
por: Maharaj, Satish, et al.
Publicado: (2017)

Carvedilol modifies antioxidant status of patients with stable angina
por: Kowalski, Jan, et al.
Publicado: (2008)

Amorphous Form of Carvedilol Phosphate—The Case of Divergent Properties
por: Sip, Szymon, et al.
Publicado: (2021)

Mechanism of carvedilol induced action potential and calcium alternans
por: Martinez-Hernandez, Elizabeth, et al.
Publicado: (2022)

The Neuroprotective Effect of Carvedilol on Diabetic Neuropathy: An In Vitro Study
por: Magadmi, Rania M., et al.
Publicado: (2021)

Carvedilol/Telmisartan/Tozinameran: Various toxicities: case report
Publicado: (2022)

Anxiolytic Effect of Carvedilol in Chronic Unpredictable Stress Model
por: de Sousa, Caren Nádia Soares, et al.
Publicado: (2022)

Effects of Carvedilol on liver ischemia-reperfusion injury in rats
por: Tolga Kafadar, Mehmet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t7kto94i0thokvd5s3j432kfsn